These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24597794)

  • 21. Comprehensive ocular and systemic pharmacokinetics of dexamethasone after subconjunctival and intravenous injections in rabbits.
    Valtari A; Posio S; Toropainen E; Balla A; Puranen J; Sadeghi A; Ruponen M; Ranta VP; Vellonen KS; Urtti A; Amo EMD
    Eur J Pharm Biopharm; 2024 May; 198():114260. PubMed ID: 38484852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of intravitreal bevacizumab (Avastin).
    Bakri SJ; Snyder MR; Reid JM; Pulido JS; Singh RJ
    Ophthalmology; 2007 May; 114(5):855-9. PubMed ID: 17467524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topotecan vitreous levels after periocular or intravenous delivery in rabbits: an alternative for retinoblastoma chemotherapy.
    Carcaboso AM; Bramuglia GF; Chantada GL; Fandiño AC; Chiappetta DA; de Davila MT; Rubio MC; Abramson DH
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3761-7. PubMed ID: 17652749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacokinetics of rituximab following an intravitreal injection.
    Kim H; Csaky KG; Chan CC; Bungay PM; Lutz RJ; Dedrick RL; Yuan P; Rosenberg J; Grillo-Lopez AJ; Wilson WH; Robinson MR
    Exp Eye Res; 2006 May; 82(5):760-6. PubMed ID: 16289160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clearance of intravitreal moxifloxacin.
    Iyer MN; He F; Wensel TG; Mieler WF; Benz MS; Holz ER
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):317-9. PubMed ID: 16384979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment.
    Buitrago E; Höcht C; Chantada G; Fandiño A; Navo E; Abramson DH; Schaiquevich P; Bramuglia GF
    Exp Eye Res; 2010 Jul; 91(1):9-14. PubMed ID: 20307538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution.
    Kane A; Barza M; Baum J
    Invest Ophthalmol Vis Sci; 1981 May; 20(5):593-7. PubMed ID: 6971281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal Pharmacokinetic Study of the Antiangiogenic Glycoprotein Opticin.
    Del Amo EM; Griffiths JR; Klaska IP; Hoke J; White A; Aarons L; Cooper GJS; Bainbridge JWB; Bishop PN; Unwin RD
    Mol Pharm; 2020 Jul; 17(7):2390-2397. PubMed ID: 32437164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of intraocular pharmacokinetics and toxicity of prinomastat (AG3340) in the rabbit.
    Cheng L; Rivero ME; Garcia CR; McDermott CD; Keefe KS; Wiley CA; Soules KA; Bergeron-Lynn G; Vekich S; Zhang K; Appelt K; Freeman WR
    J Ocul Pharmacol Ther; 2001 Jun; 17(3):295-304. PubMed ID: 11436949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
    Sigurdsson HH; Konráethsdóttir F; Loftsson T; Stefánsson E
    Acta Ophthalmol Scand; 2007 Sep; 85(6):598-602. PubMed ID: 17645424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes.
    Fialho SL; Rêgo MB; Siqueira RC; Jorge R; Haddad A; Rodrigues AL; Maia-Filho A; Silva-Cunha A
    Curr Eye Res; 2006 Jun; 31(6):525-34. PubMed ID: 16769612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearance of intravitreal voriconazole.
    Shen YC; Wang MY; Wang CY; Tsai TC; Tsai HY; Lee YF; Wei LC
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2238-41. PubMed ID: 17460285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraocular toxicity and pharmacokinetics of candesartan in a rabbit model.
    Lee JE; Lim DW; Park HJ; Shin JH; Lee SM; Oum BS
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):2924-9. PubMed ID: 21228384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbits.
    López-Cortés LF; Ruiz-Valderas R; Lucero-Muñoz MJ; Cordero E; Pastor-Ramos MT; Marquez J
    Antimicrob Agents Chemother; 2000 Mar; 44(3):756-9. PubMed ID: 10681351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal pharmacokinetics in rabbits of the foscarnet lipid prodrug: 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA).
    Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Severson GM; Freeman WR
    Curr Eye Res; 1999 Mar; 18(3):161-7. PubMed ID: 10342370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the functional importance of organic cation transporters on the ocular disposition of its intravitreally injected substrate in rabbits.
    Nirmal J; Velpandian T; Singh SB; Biswas NR; Azad R; Thavaraj V; Mittal G; Bhatnagar A; Ghose S
    Curr Eye Res; 2012 Dec; 37(12):1127-35. PubMed ID: 22916711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary study of a controllable device for subtenon drug infusion in a rabbit model.
    Duan Y; Yang Y; Huang X; Lin D
    Acta Ophthalmol; 2017 Sep; 95(6):595-601. PubMed ID: 28391654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification and structure elucidation of in vivo bevacizumab modification in rabbit vitreous humor after intravitreal injection.
    Chu KO; Liu DT; Chan KP; Yang YP; Yam GH; Rogers MS; Pang CP
    Mol Pharm; 2012 Dec; 9(12):3422-33. PubMed ID: 23094698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular pharmacokinetics of ranibizumab in vitrectomized versus nonvitrectomized eyes.
    Ahn SJ; Ahn J; Park S; Kim H; Hwang DJ; Park JH; Park JY; Chung JY; Park KH; Woo SJ
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):567-73. PubMed ID: 24398088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.